FDA Approves Erelzi Biosimilar for Enbrel

WEDNESDAY, Aug. 31, 2016 — A new biological drug to treat rheumatoid arthritis and other inflammatory diseases has been approved by the U.S. Food and Drug Administration.
The drug Erelzi (etanercept-szzs) is a “biosimilar” to Enbrel (etanercept),…
Source: Topamax